102 related articles for article (PubMed ID: 32484211)
1. Novel pyrano 1,3 oxazine based ligand inhibits the epigenetic reader hBRD2 in glioblastoma.
Deshmukh P; Mathur S; Gangadharan G; Krishnappa G; Dalavaikodihalli Nanjaiah N; Padmanabhan B
Biochem J; 2020 Jun; 477(12):2263-2279. PubMed ID: 32484211
[TBL] [Abstract][Full Text] [Related]
2. Structural investigation of a pyrano-1,3-oxazine derivative and the phenanthridinone core moiety against BRD2 bromodomains.
Arole AH; Deshmukh P; Sridhar A; Padmanabhan B
Acta Crystallogr F Struct Biol Commun; 2022 Mar; 78(Pt 3):119-127. PubMed ID: 35234137
[TBL] [Abstract][Full Text] [Related]
3. BET bromodomain proteins are required for glioblastoma cell proliferation.
Pastori C; Daniel M; Penas C; Volmar CH; Johnstone AL; Brothers SP; Graham RM; Allen B; Sarkaria JN; Komotar RJ; Wahlestedt C; Ayad NG
Epigenetics; 2014 Apr; 9(4):611-20. PubMed ID: 24496381
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain.
Umehara T; Nakamura Y; Jang MK; Nakano K; Tanaka A; Ozato K; Padmanabhan B; Yokoyama S
J Biol Chem; 2010 Mar; 285(10):7610-8. PubMed ID: 20048151
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4.
Nakamura Y; Umehara T; Nakano K; Jang MK; Shirouzu M; Morita S; Uda-Tochio H; Hamana H; Terada T; Adachi N; Matsumoto T; Tanaka A; Horikoshi M; Ozato K; Padmanabhan B; Yokoyama S
J Biol Chem; 2007 Feb; 282(6):4193-201. PubMed ID: 17148447
[TBL] [Abstract][Full Text] [Related]
6. A Novel Phenanthridionone Based Scaffold As a Potential Inhibitor of the BRD2 Bromodomain: Crystal Structure of the Complex.
Tripathi S; Mathur S; Deshmukh P; Manjula R; Padmanabhan B
PLoS One; 2016; 11(5):e0156344. PubMed ID: 27243809
[TBL] [Abstract][Full Text] [Related]
7. Structural implications for K5/K12-di-acetylated histone H4 recognition by the second bromodomain of BRD2.
Umehara T; Nakamura Y; Wakamori M; Ozato K; Yokoyama S; Padmanabhan B
FEBS Lett; 2010 Sep; 584(18):3901-8. PubMed ID: 20709061
[TBL] [Abstract][Full Text] [Related]
8. Solution structure of the second bromodomain of Brd2 and its specific interaction with acetylated histone tails.
Huang H; Zhang J; Shen W; Wang X; Wu J; Wu J; Shi Y
BMC Struct Biol; 2007 Sep; 7():57. PubMed ID: 17848202
[TBL] [Abstract][Full Text] [Related]
9. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation.
Pastori C; Kapranov P; Penas C; Peschansky V; Volmar CH; Sarkaria JN; Bregy A; Komotar R; St Laurent G; Ayad NG; Wahlestedt C
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8326-31. PubMed ID: 26111795
[TBL] [Abstract][Full Text] [Related]
10. OTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models.
Berenguer-Daizé C; Astorgues-Xerri L; Odore E; Cayol M; Cvitkovic E; Noel K; Bekradda M; MacKenzie S; Rezai K; Lokiec F; Riveiro ME; Ouafik L
Int J Cancer; 2016 Nov; 139(9):2047-55. PubMed ID: 27388964
[TBL] [Abstract][Full Text] [Related]
11. Insights into the crystal structure of BRD2-BD2 - phenanthridinone complex and theoretical studies on phenanthridinone analogs.
Mathur S; Deshmukh P; Tripathi S; Marimuthu P; Padmanabhan B
J Biomol Struct Dyn; 2018 Jul; 36(9):2342-2360. PubMed ID: 28696179
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel BRD4 inhibitors by high-throughput screening, crystallography, and cell-based assays.
Sun Z; Zhang H; Chen Z; Xie Y; Jiang H; Chen L; Ding H; Zhang Y; Jiang H; Zheng M; Luo C
Bioorg Med Chem Lett; 2017 May; 27(9):2003-2009. PubMed ID: 28347667
[TBL] [Abstract][Full Text] [Related]
13. Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma.
Xu L; Chen Y; Mayakonda A; Koh L; Chong YK; Buckley DL; Sandanaraj E; Lim SW; Lin RY; Ke XY; Huang ML; Chen J; Sun W; Wang LZ; Goh BC; Dinh HQ; Kappei D; Winter GE; Ding LW; Ang BT; Berman BP; Bradner JE; Tang C; Koeffler HP
Proc Natl Acad Sci U S A; 2018 May; 115(22):E5086-E5095. PubMed ID: 29764999
[TBL] [Abstract][Full Text] [Related]
14. BRD4: New hope in the battle against glioblastoma.
Duan W; Yu M; Chen J
Pharmacol Res; 2023 May; 191():106767. PubMed ID: 37061146
[TBL] [Abstract][Full Text] [Related]
15. The Epigenetic Reader BRD2 as a Specific Modulator of PAI-1 Expression in Lipopolysaccharide-Stimulated Mouse Primary Astrocytes.
Choi CS; Hong SH; Sim S; Cho KS; Kim JW; Yang SM; Jeon SJ; You JS; Shin CY
Neurochem Res; 2015 Nov; 40(11):2211-9. PubMed ID: 26349765
[TBL] [Abstract][Full Text] [Related]
16. Structural basis and binding properties of the second bromodomain of Brd4 with acetylated histone tails.
Liu Y; Wang X; Zhang J; Huang H; Ding B; Wu J; Shi Y
Biochemistry; 2008 Jun; 47(24):6403-17. PubMed ID: 18500820
[TBL] [Abstract][Full Text] [Related]
17. Structural and biochemical insights into purine-based drug molecules in hBRD2 delineate a unique binding mode opening new vistas in the design of inhibitors of the BET family.
Arole AH; Deshmukh P; Sridhar A; Mathur S; Mahalingaswamy M; Subramanya H; Dalavaikodihalli Nanjaiah N; Padmanabhan B
Acta Crystallogr D Struct Biol; 2023 Aug; 79(Pt 8):758-774. PubMed ID: 37432115
[TBL] [Abstract][Full Text] [Related]
18. RVX-297- a novel BD2 selective inhibitor of BET bromodomains.
Kharenko OA; Gesner EM; Patel RG; Norek K; White A; Fontano E; Suto RK; Young PR; McLure KG; Hansen HC
Biochem Biophys Res Commun; 2016 Aug; 477(1):62-67. PubMed ID: 27282480
[TBL] [Abstract][Full Text] [Related]
19. High resolution crystal structure of BRD4-BD1 in complex with a novel inhibitor precursor.
Ma X; Wang M; Wang F; Li J; Zhang Z; Zhu J; Liu B
Biochem Biophys Res Commun; 2024 Jan; 690():149284. PubMed ID: 38006801
[TBL] [Abstract][Full Text] [Related]
20. The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins.
Taniguchi Y
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
